A combined assay of hTERT and E6 oncoprotein to identify virus-infected keratinocytes with higher telomerase activity in human papillomaviruses 16 and 18-related bowenoid papulosis

American Journal of Dermatopathology

Volumn 34, Issue 8, 2012, Pages 813-817

  Li, Dongsheng ^a   Dong, Bilin ^a   Hu, Zhimin ^a   Chen, Liuqing ^a   Zeng, Xianyu ^a   Chen, Jinbo ^a   Duan, Yiqun ^a  

^a No 1 Hospital of Wuhan   (China)

Author keywords

Bowenoid papulosis; E6 oncoprotein; Human papillomavirus; Human telomerase reverse transcriptase; Screening

Indexed keywords

PROTEIN E6; TELOMERASE REVERSE TRANSCRIPTASE; VIRUS DNA;

ARTICLE; BOWENOID PAPULOSIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MITOSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

BOWEN'S DISEASE; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; SKIN DISEASES, PAPULOSQUAMOUS; TELOMERASE;

EID: 84870067067     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318252f956     Document Type: Article

References (27)

1. Schwartz RA, Janniger CK. Bowenoid papulosis. J Am Acad Dermatol. 1991;24: 261-264.
2. Fleury FJ. Bowenoid papulosis of the genitalia. Arch Dermatol. 1980; 116:274.
3. Crum CP, Liskow A, Petras P, et al. Vulvar intraepithelial neoplasia (severe atypia and carcinoma in situ). A clinicopathologic analysis of 41 cases. Cancer. 1984;54: 1429-1434.
4. Lookingbill DP, Kreider JW, Howett MK, et al. Human papillomavirus type 16 in bowenoid papulosis, intraoral papillomas, and squamous cell carcinoma of the tongue. Arch Dermatol. 1987;123: 363-368.
5. Rüdlinger R, Grob R, Yu YX, et al. Human papillomavirus-35-positive bowenoid papulosis of the anogenital area and concurrent human papillomavirus- 35-positive verruca with bowenoid dysplasia of the periungual area. Arch Dermatol. 1989;125: 655-659.
6. Abdennader S, Lessana-Leibowitch M, Pelisse M. An atypical case of penile carcinoma in situ associated with human papillomavirus DNA type 18. J Am Acad Dermatol. 1989;20: 887-889.
7. Jablonska S, Majewski S. Bowenoid papulosis transforming into squamous cell carcinoma of the genitalia. Br J Dermatol. 1999;141: 156-157.
8. Nishimura Y, Kishigawa T, Tanaka T. Bilateral Bowen's disease. Br J Dermatol. 2004;151: 227-228.
9. Mitsuishi T, Iwabu Y, Tokunaga K, et al. Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors. BMC Cancer. 2010;10:118.
10. Hama N, Ohtsuka T, Yamazaki S. Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin. J Dermatol. 2006;33: 331-337.
11. Lucker GP, Speel EJ, Creytens DH, et al. Differences in imiquimod treatment outcome in two patients with bowenoid papulosis containing either episomal or integrated human papillomavirus 16. J Invest Dermatol. 2007;127: 727-729.
12. Park KC, Kim KH, Youn SW, et al. Heterogeneity of human papillomavirus DNA in a patient with Bowenoid papulosis that progressed to squamous cell carcinoma. Br J Dermatol. 1998;139: 1087-1091.
13. Henquet CJ. Anogenital malignancies and pre-malignancies. J Eur Acad Dermatol Venereol. 2011;25: 885-895.
14. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol. 1997;36: 659-685.
15. Rognozinski TT, Janniger CK. Bowenoid papulosis. Am Fam Physician. 1988;38: 161-164.
16. Lingner J, Hughes TR, Shevchenko A, et al. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 1997;276: 561-567.
17. Nugent CI, Lundblad V. The telomerase reverse transcriptase: components and regulation. Genes Dev. 1998;12: 1073-1085.
18. Liu X, Dakic A, Zhang Y, et al. HPV E6 protein interacts physically and functionally with the cellular telomerase complex. Proc Natl Acad Sci U S A. 2009;106: 18780-18785.
19. Katzenellenbogen RA, Vliet-Gregg P, Xu M, et al. NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes. J Virol. 2009;83: 6446-6456.
20. McMurray HR, McCance DJ. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol. 2003;77: 9852-9861.
21. Veldman T, Horikawa I, Barrett JC, et al. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol. 2001;75: 4467-4472.
22. Veldman T, Liu X, Yuan H, et al. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci U S A. 2003;100: 8211-8216.
23. Wisman GB, Knol AJ, Helder MN, et al. Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer. Int J Cancer. 2001;91: 658-664.
24. Cheng YW, Wu TC, Chen CY, et al. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis. Clin Cancer Res. 2008;14: 7173-7179.
25. Liu H, Urabe K, Moroi Y, et al. Expression of p16 and hTERT protein is associated with the presence of high-risk human papillomavirus in bowenoid papulosis. J Cutan Pathol. 2006;33: 551-558.
26. Snow AN, Laudadio J. Human papillomavirus detection in head and neck squamous cell carcinomas. Adv Anat Pathol. 2010;17: 394-403.
27. Ferber MJ, Montoya DP, Yu C, et al. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene. 2003;22: 3813-3820.